Novartis will continue to do bolt-on deals and its capital allocation priorities remain unchanged, CEO Vasant Narasimhan said ...

TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts on prescription drugs will work ...

Beginning this year, Medicare's new negotiated drug prices could cut prescription costs in half for millions of seniors, a ...

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the maximum price drug manufacturers can charge Medicare plans for 10 popular ...

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the ...

Savings for Part D and Advantage enrollees depend largely on which plan they’re enrolled in, as not all plans are the same.

There’s good news in 2026 for seniors enrolled in Medicare Part D who rely on the priciest prescription drugs: 10 high-cost ...

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

Fast growth for recently label-expanded drugs fuelled Novartis’ Q3 performance, despite headwinds from generic competition affecting more established blockbusters. Net sales for the Swiss big pharma ...